Agilent/Dako

PD-L1 IHC 22C3 pharmDx for Autostainer Link 48

#SK006 · immunohistochemistry

59

Citing papers

1.5k

Combined citations

Supplier page Find this product

Research areas

Cancer Immunotherapy and Biomarkers35 Immunotherapy and Immune Responses10 CAR-T cell therapy research8 Immune Cell Function and Interaction7 Cancer Genomics and Diagnostics6 Lung Cancer Treatments and Mutations6 Ferroptosis and cancer prognosis4 Inflammatory Biomarkers in Disease Prognosis4

Papers citing this product

1

Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis

Journal of Clinical Investigation·2021·329 cit.·DOI

2

Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer

Journal of Nuclear Medicine·2019·164 cit.·DOI

3

Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

Modern Pathology·2019·87 cit.·DOI

4

Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study

npj Breast Cancer·2022·81 cit.·DOI

5

Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray

Laboratory Investigation·2019·66 cit.·DOI

6

Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma

Journal for ImmunoTherapy of Cancer·2017·59 cit.·DOI

7

Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression

Cancers·2020·51 cit.·DOI

8

Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer

Nature Communications·2021·50 cit.·DOI

9

Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation

JCI Insight·2021·47 cit.·DOI

10

CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer

BMC Gastroenterology·2023·46 cit.·DOI

Also available from other vendors

This target has 114 citing papers across all vendors combined

Vendor	Product	Evidence	Price	Papers
Agilent/Dako	CD 274, Programmed cell death 1 ligand 1 (B7-H1)	—	—	56

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.